PRE Q3 2025 Earnings — Prenetics Global Limited Revenue & Financial Results | Market Cap Arena

PREPrenetics Global Limited

$287M

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$24M+202.8% YoY

Gross Profit

$14M59.5% margin

Operating Income

-$6M-26.2% margin

Net Income

-$7M-31.4% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

+33.2%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$197M

Total Liabilities

$35M

Stockholders' Equity

$161M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$8M	+202.8%
Gross Profit	$14M	$4M	+255.3%
Operating Income	-$6M	-$12M	+47.8%
Net Income	-$7M	-$11M	+30.6%